Covered recipient · General Payments record
MICHAEL CECCHINI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$87,281.00
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $13,465.00 | 5 |
| Travel and Lodging | $10,317.75 | 9 |
| Food and Beverage | $511.59 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $8,068.52 | 6 |
| Ipsen Pharma SAS | $7,906.26 | 5 |
| TAIHO ONCOLOGY, INC. | $6,358.49 | 3 |
| Eli Lilly and Company | $1,914.58 | 4 |
| Genentech USA, Inc. | $46.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BeiGene USA, Inc. | $1,500.00 | 06/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1120846650 | CMS |
| BeiGene USA, Inc. | $2,625.00 | 06/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120846652 | CMS |
| BeiGene USA, Inc. | $107.33 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120859245 | CMS |
| BeiGene USA, Inc. | $290.00 | 06/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1120859247 | CMS |
| BeiGene USA, Inc. | $546.19 | 06/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1120859249 | CMS |
| BeiGene USA, Inc. | $3,000.00 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120846654 | CMS |
| Eli Lilly and Company | $207.00 | 02/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135190131 | CMS |
| Eli Lilly and Company | $24.00 | 02/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135171612 | CMS |
| Eli Lilly and Company | $83.58 | 02/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135171614 | CMS |
| Eli Lilly and Company | $1,600.00 | 02/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135203990 | CMS |
| Genentech USA, Inc. | $46.49 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133069268 | CMS |
| Ipsen Pharma SAS | $6,860.60 | 09/25/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1071126147 | CMS |
| Ipsen Pharma SAS | $129.94 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1071126141 | CMS |
| Ipsen Pharma SAS | $644.38 | 09/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1071126145 | CMS |
| Ipsen Pharma SAS | $109.34 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1071126139 | CMS |
| Ipsen Pharma SAS | $162.00 | 10/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1071126143 | CMS |
| TAIHO ONCOLOGY, INC. | $118.49 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137939576 | CMS |
| TAIHO ONCOLOGY, INC. | $2,340.00 | 06/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1137934957 | CMS |
| TAIHO ONCOLOGY, INC. | $3,900.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1137942408 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.